![]() |
|
|
Vol. 28, Issue 1, 38-43, January 2000
Department of Drug Metabolism and Pharmacokinetics, Schering-Plough
Research Institute, Kenilworth, New Jersey
Organic solvents are often used to solubilize lipophilic new
chemical entities before their addition to in vitro test systems such
as microsomal stability or cytochrome P-450 (CYP) inhibition. However,
the effect of these organic solvents on the test systems is not usually
characterized. This study was initiated to evaluate the effect of
acetonitrile and acetone, in addition to other organic solvents, on the
tolbutamide hydroxylation activity of CYP2C9 in both human liver
microsomes and a CYP2C9-reconstituted system. Both acetonitrile and
acetone significantly stimulated the NADPH-dependent tolbutamide
hydroxylation by nearly 2- to 3-fold in human liver microsomes and
CYP2C9-reconstituted system when incubated at 2 and 4% final solvent
concentrations. When cumene hydroperoxide was used instead of NADPH,
both acetone and acetonitrile significantly inhibited tolbutamide
hydroxylation. This NADPH-dependent stimulatory effect was further
evaluated by examining the effect of a series of other organic solvents
with different carbon chain lengths and various functional groups,
including hydroxyl, ketone, and aldehyde. Unlike acetone, two other
ketone-containing solvents, methyl ethyl ketone (2-butanone) and
diethyl ketone (3-pentanone) failed to significantly enhance
tolbutamide hydroxylation. Other solvents tested, including methanol,
ethanol, propanol, 1-butanol, 2-butanol, 1-pentanol, 2-pentanol,
acetaldehyde, and dimethyl sulfoxide significantly inhibited
NADPH-dependent tolbutamide hydroxylation. Overall, the stimulatory
effect of both acetonitrile and acetone on tolbutamide hydroxylation
was found to be primarily due to a consistent increase in
Vmax, whereas Km
was unchanged in both human liver microsomes and the reconstituted
CYP2C9 system. These data suggest that acetone and acetonitrile
stimulate NADPH-mediated tolbutamide hydroxylation via the CYP
reductase and not by modifying the affinity of tolbutamide for the
CYP2C9 enzyme.
This article has been cited by other articles:
![]() |
M. Giantin, M. Carletti, F. Capolongo, S. Pegolo, R. M. Lopparelli, F. Gusson, C. Nebbia, M. Cantiello, P. Martin, T. Pineau, et al. Effect of Breed upon Cytochromes P450 and Phase II Enzyme Expression in Cattle Liver Drug Metab. Dispos., May 1, 2008; 36(5): 885 - 893. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Walsky and R. S. Obach VALIDATED ASSAYS FOR HUMAN CYTOCHROME P450 ACTIVITIES Drug Metab. Dispos., June 1, 2004; 32(6): 647 - 660. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Hutzler and T. S. Tracy Atypical Kinetic Profiles in Drug Metabolism Reactions Drug Metab. Dispos., April 1, 2002; 30(4): 355 - 362. [Full Text] [PDF] |
||||
![]() |
J. R. Palamanda, C. N. Casciano, L. A. Norton, R. P. Clement, L. V. Favreau, C.-c. Lin, and A. A. Nomeir Mechanism-Based Inactivation of CYP2D6 by 5-Fluoro-2-[4-[(2-phenyl-1H-imidazol-5-yl)methyl]-1-piperazinyl]pyrimidine Drug Metab. Dispos., June 1, 2001; 29(6): 863 - 867. [Abstract] [Full Text] |
||||
![]() |
H. Yin, P. Tran, G. E. Greenberg, and V. Fischer Methanol Solvent May Cause Increased Apparent Metabolic Instability in in Vitro Assays Drug Metab. Dispos., February 1, 2001; 29(2): 185 - 193. [Abstract] [Full Text] |
||||
![]() |
C. Tang, M. Shou, and A. D. Rodrigues Substrate-Dependent Effect of Acetonitrile on Human Liver Microsomal Cytochrome P450 2C9 (CYP2C9) Activity Drug Metab. Dispos., May 1, 2000; 28(5): 567 - 572. [Abstract] [Full Text] |
||||